Tag: TWN ASA CHN CLF UWS USA NAM

HanchorBio and Henlius Sign Major Licensing Deal for HCB101 to Expand Global Immuno-Oncology Reach

TAIPEI and SHANGHAI and SAN FRANCISCO, July 1, 2025 /PRNewswire/ -- HanchorBio Inc. (7827.TWO), a global clinical-stage biotechnology company developing innovative immunotherapies for oncology...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsTWN ASA CHN CLF UWS USA NAM

Kingworld Medicines Group (01110.HK) Signs MOU to Pursue Exclusive Distribution Rights for Two Lingnan Formula Products

Banqup Group Announces Strategic Simplification Plan and Launch of Process to Explore Strategic Alternatives

We Mean Business Coalition: New polling shows overwhelming global business support for clean electrification amid fossil fuel volatility

Tag: TWN ASA CHN CLF UWS USA NAM

HanchorBio and Henlius Sign Major Licensing Deal for HCB101 to Expand Global Immuno-Oncology Reach

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us